Effective and Tolerable Treatment of Advanced Basal Cell Carcinoma With Vismodegib Despite Renal Insufficiency

JAMA Dermatol. 2016 Dec 1;152(12):1387-1388. doi: 10.1001/jamadermatol.2015.4592.

Authors

Lara Valeska Maul¹, Katharina C Kähler¹, Axel Hauschild¹

Affiliation

¹ Department of Dermatology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.

PMID: 26720040
DOI: 10.1001/jamadermatol.2015.4592

No abstract available

Publication types

Case Reports
Research Support, Non-U.S. Gov't

MeSH terms

Aged
Anilides / administration & dosage*
Anilides / adverse effects
Anilides / pharmacokinetics
Biopsy
Carcinoma, Basal Cell / drug therapy*
Carcinoma, Basal Cell / metabolism
Carcinoma, Basal Cell / pathology
Dose-Response Relationship, Drug
Humans
Male
Pyridines / administration & dosage*
Pyridines / adverse effects
Pyridines / pharmacokinetics
Renal Insufficiency / chemically induced*
Skin / drug effects
Skin / pathology*
Skin Neoplasms / drug therapy*
Skin Neoplasms / metabolism
Skin Neoplasms / pathology

Substances

Anilides
HhAntag691
Pyridines